(4-DIMETHYLAMINO-BENZYL)-(2,2,6,6-TETRAMETHYL-PIPERIDIN-4-YL)-AMINE
|
- $378 - $874
- Product name: (4-DIMETHYLAMINO-BENZYL)-(2,2,6,6-TETRAMETHYL-PIPERIDIN-4-YL)-AMINE
- CAS: 443903-18-2
- MF: C18H31N3
- MW: 289.46
- EINECS:
- MDL Number:MFCD03036627
- Synonyms:(4-DIMETHYLAMINO-BENZYL)-(2,2,6,6-TETRAMETHYL-PIPERIDIN-4-YL)-AMINE;TIMTEC-BB SBB007397;4-Piperidinamine, N-[[4-(dimethylamino)phenyl]methyl]-2,2,6,6-tetramethyl-
3 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0081100
- Product description(4-DIMETHYLAMINO-BENZYL)-(2,2,6,6-TETRAMETHYL-PIPERIDIN-4-YL)-AMINE 95.00%
- Packaging500MG
- Price$768.08
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11122792
- Product descriptionN-(4-(Dimethylamino)benzyl)-2,2,6,6-tetramethylpiperidin-4-amine 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number010897
- Product description(4-Dimethylamino-benzyl)-(2,2,6,6-tetramethyl-piperidin-4-yl)-amine
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM0081100 | (4-DIMETHYLAMINO-BENZYL)-(2,2,6,6-TETRAMETHYL-PIPERIDIN-4-YL)-AMINE 95.00% | 500MG | $768.08 | 2021-12-16 | Buy |
| Crysdot | CD11122792 | N-(4-(Dimethylamino)benzyl)-2,2,6,6-tetramethylpiperidin-4-amine 97% | 5g | $874 | 2021-12-16 | Buy |
| Matrix Scientific | 010897 | (4-Dimethylamino-benzyl)-(2,2,6,6-tetramethyl-piperidin-4-yl)-amine | 1g | $378 | 2021-12-16 | Buy |
Properties
Boiling point :394.0±37.0 °C(Predicted)
Density :0.99±0.1 g/cm3(Predicted)
pka :10.87±0.10(Predicted)
Density :0.99±0.1 g/cm3(Predicted)
pka :10.87±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|